Remicade and Hyperacusis - a phase IV clinical study of FDA data

Summary:

Hyperacusis is reported as a side effect among people who take Remicade (infliximab), especially for people who are female, 40-49 old, have been taking the drug for < 1 month also take Enbrel, and have Ankylosing spondylitis.

The phase IV clinical study analyzes which people have Hyperacusis when taking Remicade. It is created by eHealthMe based on reports of 222,651 people who have side effects when taking Remicade from the FDA, and is updated regularly.

What is Remicade?

Remicade has active ingredients of infliximab. It is often used in crohn's disease. eHealthMe is studying from 224,009 Remicade users. Check the latest studies of Remicade.

What is Hyperacusis?

Hyperacusis (disorder in loudness perception) is found to be associated with 475 drugs and 600 conditions by eHealthMe. Check the latest studies of Hyperacusis.

On Aug, 05, 2025

222,651 people reported to have side effects when taking Remicade.
Among them, 23 people (0.01%) have Hyperacusis.

Among these 23 people:

How long have people been on Remicade when they have Hyperacusis? *

What is the gender of people who have Hyperacusis when taking Remicade? *

female: 100 %
male: 0.0 %

What is the age of people who have Hyperacusis when taking Remicade? *

What are other drugs people take besides Remicade? *

What are other side effects people have besides Hyperacusis? *

Headache (pain in head): 17 people, 73.91%
Photophobia (extreme sensitivity to light): 17 people, 73.91%
Nausea (feeling of having an urge to vomit): 15 people, 65.22%
Fatigue (feeling of tiredness): 15 people, 65.22%
Back Pain: 14 people, 60.87%
Migraine (headache): 14 people, 60.87%
Joint Pain: 13 people, 56.52%
Skin Discomfort (skin pain/irritation): 13 people, 56.52%
Secretion Discharge: 13 people, 56.52%
Joint Swelling: 13 people, 56.52%

What are the existing conditions these people have? *

Ankylosing Spondylitis (type of arthritis affecting the spine): 11 people, 47.83%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 4.35%
Headache (pain in head): 1 person, 4.35%
Arthritis Reactive (autoimmune condition that develops in response to an infection in another part of the body): 1 person, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Remicade and have Hyperacusis?

- Check whether Hyperacusis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Remicade:

Remicade (224,009 reports)

Hyperacusis treatments and more:

Hyperacusis (4,388 reports)

How severe was Hyperacusis and when was it recovered:

Hyperacusis in Remicade

Browse all side effects of Remicade:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperacusis:

Hyperacusis (475 drugs)

Browse all the conditions that are associated with Hyperacusis:

Hyperacusis (600 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on infliximab (the active ingredients of Remicade) and Remicade (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.